Terminal
Stocks
Spotlight
Research

Stocks
Healthcare
NASDAQ
CAI

Market Cap: $6.88B

CI

Caris Life Sciences, Inc.

CAI

NASDAQ (NASDAQ Global Select)USD

Overview News Analyst Reports Financials Politician Trades Insider Trades Executive Patents Earnings Surprise

By Cashu Finance. Providing market news, analysis, and research for investors worldwide.

Company

Stocks About Advertisers Brokers Contact

Legal

Terms of Service Privacy Policy

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Finance is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Finance is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Finance and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Financials

Profitability

Gross Profit Margin69.66%

EBITDA Margin17.45%

EBIT Margin15.35%

Pre-tax Margin10.61%

Net Profit Margin10.62%

Earnings Yield1.53%

Valuation Multiples

Price / Book11.64

Price / Sales6.95

Price / Earnings65.45

PEG0.24

Forward PEG0.34

EV / Sales6.71

EV / EBITDA38.46

EV / Operating Cash Flow32.97

EV / Free Cash Flow45.34

Price / Free Cash Flow46.97

Price / Operating Cash Flow34.18

Cash Flow & Capital

Free Cash Flow / Share$0.52

Operating Cash Flow / Share$0.71

Free Cash Flow Yield2.13%

Capex / Revenue5.55%

Capex / Operating Cash Flow27.28%

Capex / Depreciation2.13

Stock Compensation / Revenue6.58%

Dividend Payout Ratio0.00%

Dividend Yield0.00%

Liquidity & Leverage

Current Ratio5.53

Quick Ratio4.88

Cash Ratio3.61

Debt / Assets0.37

Debt / Capital0.43

Debt / Equity0.76

Long-Term Debt / Capital0.40

Debt / Market Cap5.71%

Net Debt / EBITDA-1.38

Solvency Ratio0.20

Financial Leverage2.08

Efficiency & Working Capital

Asset Turnover0.80

Fixed Asset Turnover10.34

Inventory Turnover2.43

Receivables Turnover8.47

Payables Turnover3.49

Days Sales Outstanding43.11

Days Inventory Outstanding150.49

Days Payables Outstanding104.53

Operating Cycle193.6

Cash Conversion Cycle89.07

Working Capital Turnover1.14

Returns & Quality

Return on Equity18.77%

Return on Assets8.55%

Return on Invested Capital14.67%

ROCE14.76%

Return on Tangible Assets8.69%

Operating Return on Assets12.81%

Income Quality1.93

Tax Burden1.00

Interest Burden0.69

Balance Sheet & Intrinsic Metrics

Enterprise Value$6.64B

Invested Capital$981.45M

Working Capital$866.39M

Tangible Asset Value$572.39M

Net Current Asset Value$419.94M

Graham Number$4.18

Graham Net-Net$1.08

Book Value / Share$2.09

Tangible Book Value / Share$2.02

Cash / Share$2.8

Financial Health Scores

Piotroski Score5

Altman Z-Score5.55

Revenue$989.61M

EBIT$151.92M

Market Cap$6.8B

Working Capital$866.39M

Retained Earnings$-2.55B

Total Assets$1.23B

Total Liabilities$637.89M